Results 181 to 190 of about 26,475 (236)

ADAR1-circRAB5A-BIP axis governs radiotherapy resistance in colorectal cancer through coordinating protective autophagy and apoptosis. [PDF]

Cancer Biol Ther
Chen W, Zhang X, Zhao Z, Xin W, Li J, Che X.   +5 more
europepmc   +1 more source

Quantitative dissection of radioresistance in cancer cells: Oxygen depletion-induced biological versus chemical mechanisms and baseline mechanisms governed by HIF-1β-NRF2/TXNRD1. [PDF]

Neoplasia
Takeuchi S, Kobayashi M, Lee PWT, Takahashi I, Yoshihara T, Harada H.   +5 more
europepmc   +1 more source

Biomarkers of radioresistance in lung cancer: Current insights and future directions (Review). [PDF]

Mol Med Rep
Attouahri FZ, Chaoui I, Laraqui A, Tagajdid MR, Oukabli M, El Marjany M, Khyatti M, Attaleb M, Ababou M, Ennibi K, Errafii K, El Mzibri M.   +11 more
europepmc   +1 more source

Salinomycin is effective for clinically relevant radioresistant oral squamous cell carcinoma cancer cells and their cancer stem cell marker positive fraction. [PDF]

Med Int (Lond)
Saga R, Hosokawa Y, Fukumoto M.
europepmc   +1 more source

Risk stratification and multi-omics reveal RAD51 inhibition as a radiosensitizing strategy in triple-negative breast cancer. [PDF]

Front Immunol
An R, Li J, Liu T, Tang C, Lu H.
europepmc   +1 more source

Integrating single-cell multi-omics for precision radiotherapy stratification in hypopharyngeal squamous cell carcinoma. [PDF]

Front Genet
Zhang W, Yao M.
europepmc   +1 more source

Beyond dose escalation in glioblastoma: Lessons learned from INTRAGO-II and the case for targeting tumor biology. [PDF]

Neuro Oncol
Layer JP, Schneider M, Hölzel M, Herrlinger U, Winkler F.   +4 more
europepmc   +1 more source

Prodigiosin in glioblastoma: mechanistic pharmacology and rationale for its development as a radiosensitiser. [PDF]

Front Pharmacol
Ray H.
europepmc   +1 more source

Radiation-Induced Alterations in Cancer-Associated Fibroblasts: Drivers of Tumor Radioresistance and Therapeutic Targets. [PDF]

Biomolecules
Shi Z, Hu C, Sun C.
europepmc   +1 more source